$ONC
BeiGene, Ltd.

2021 Q2 Form 10-Q Financial Statement

#000165130821000172 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $150.0M $65.64M
YoY Change 128.52% -73.03%
Cost Of Revenue $36.26M $14.31M
YoY Change 153.46% -19.8%
Gross Profit $113.7M $51.33M
YoY Change 121.57% -77.24%
Gross Profit Margin 75.82% 78.2%
Selling, General & Admin $232.3M $124.0M
YoY Change 87.26% 50.82%
% of Gross Profit 204.25% 241.68%
Research & Development $356.1M $286.0M
YoY Change 24.52% 25.01%
% of Gross Profit 313.1% 557.14%
Depreciation & Amortization $11.22M $7.679M
YoY Change 46.15% 128.34%
% of Gross Profit 9.87% 14.96%
Operating Expenses $588.4M $410.0M
YoY Change 43.5% 31.83%
Operating Profit -$474.8M -$358.9M
YoY Change 32.31% 318.11%
Interest Expense -$55.21M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$867.0K $19.98M
YoY Change -104.34% -2375.17%
Pretax Income -$480.6M -$337.8M
YoY Change 42.27% 302.97%
Income Tax -$230.0K -$1.475M
% Of Pretax Income
Net Earnings -$480.3M -$335.2M
YoY Change 43.3% 291.73%
Net Earnings / Revenue -320.24% -510.71%
Basic Earnings Per Share -$0.40 -$0.33
Diluted Earnings Per Share -$0.40
COMMON SHARES
Basic Shares Outstanding 1.194B shares 1.010B shares
Diluted Shares Outstanding 1.194B shares 1.010B shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.382B $3.153B
YoY Change 38.99%
Cash & Equivalents $1.776B $1.345B
Short-Term Investments $2.605B $1.808B
Other Short-Term Assets $1.024B
YoY Change
Inventory $117.6M $33.23M
Prepaid Expenses
Receivables $73.79M $61.66M
Other Receivables $3.504M
Total Short-Term Assets $4.799B $3.392B
YoY Change 41.46% 93.22%
LONG-TERM ASSETS
Property, Plant & Equipment $395.2M $258.1M
YoY Change 53.1% 21.36%
Goodwill $109.0K $109.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $348.5M $26.24M
YoY Change 1227.99%
Other Assets $132.2M $112.4M
YoY Change 17.67% 86.81%
Total Long-Term Assets $725.1M $510.9M
YoY Change 41.93% 29.46%
TOTAL ASSETS
Total Short-Term Assets $4.799B $3.392B
Total Long-Term Assets $725.1M $510.9M
Total Assets $5.524B $3.903B
YoY Change 41.52% 81.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $168.8M $157.2M
YoY Change 7.41% 5.81%
Accrued Expenses $398.9M $207.9M
YoY Change 91.83%
Deferred Revenue $63.61M
YoY Change
Short-Term Debt $2.716B
YoY Change
Long-Term Debt Due 2.807B CNies $26.06M
YoY Change 10672.22% 198.18%
Total Short-Term Liabilities $1.242B $551.2M
YoY Change 125.39% 102.88%
LONG-TERM LIABILITIES
Long-Term Debt 1.258B CNies $131.5M
YoY Change 856.8% 55.63%
Other Long-Term Liabilities $55.33M $46.51M
YoY Change 18.96% 22.08%
Total Long-Term Liabilities $675.0M $805.6M
YoY Change -16.21% 162.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.242B $551.2M
Total Long-Term Liabilities $675.0M $805.6M
Total Liabilities $1.917B $1.357B
YoY Change 41.31% 134.31%
SHAREHOLDERS EQUITY
Retained Earnings -$3.967B -$2.655B
YoY Change 49.41% 110.63%
Common Stock $120.0K $102.0K
YoY Change 17.65% 30.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.607B $2.536B
YoY Change
Total Liabilities & Shareholders Equity $5.524B $3.903B
YoY Change 41.52% 81.52%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$480.3M -$335.2M
YoY Change 43.3% 291.73%
Depreciation, Depletion And Amortization $11.22M $7.679M
YoY Change 46.15% 128.34%
Cash From Operating Activities -$2.739B
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$269.5M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.396B
YoY Change
Cash From Investing Activities $2.127B
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0M
YoY Change
NET CHANGE
Cash From Operating Activities -2.739B
Cash From Investing Activities 2.127B
Cash From Financing Activities 140.0M
Net Change In Cash -472.2M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.739B
Capital Expenditures -$269.5M
Free Cash Flow -$2.470B
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001651308
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37686
dei Entity Registrant Name
EntityRegistrantName
BEIGENE, LTD.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1209416
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Mourant Governance Services (Cayman) Limited
dei Entity Address Address Line2
EntityAddressAddressLine2
94 Solaris Avenue, Camana Bay
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Address Country
EntityAddressCountry
KY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1108
dei City Area Code
CityAreaCode
345
dei Local Phone Number
LocalPhoneNumber
949-4123
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BGNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1211067023 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 us-gaap Inventory Net
InventoryNet
117587000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
395167000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357686000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1776448000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1381950000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
310000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
307000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2605452000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3268725000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
73787000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60403000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
89293000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
225455000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160012000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
4799039000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
4960690000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9927000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7748000 USD
CY2021Q2 us-gaap Assets
Assets
5524116000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
95980000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90581000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12008000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5000000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
79751000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
65962000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
132244000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
113090000 USD
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
725077000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
640067000 USD
CY2020Q4 us-gaap Assets
Assets
5600757000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
168826000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
231957000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
398856000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
346144000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
63605000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 USD
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
13855000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
20380000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16550000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13895000 USD
CY2021Q2 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
145820000 USD
CY2020Q4 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
127808000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
434802000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
335015000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1242314000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1075199000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
194856000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
183637000 USD
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
75272000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34172000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29417000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12270000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10792000 USD
CY2021Q2 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
303126000 USD
CY2020Q4 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
375040000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55331000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57429000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
675027000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
656315000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1917341000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1731514000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1204567023 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1204567023 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1190821941 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1190821941 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
120000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7561155000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7414932000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12095000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6942000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3966595000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3552749000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
3606775000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3869243000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5524116000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5600757000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
149992000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65635000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
755864000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117694000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36263000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14307000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68948000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28456000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
356091000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
285968000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
676817000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
590270000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
232289000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124049000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
414395000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
231130000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
624830000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
424512000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1160535000 USD
us-gaap Costs And Expenses
CostsAndExpenses
850327000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-474838000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-358877000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-404671000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-732633000 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4866000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1108000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9045000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7798000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-867000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19976000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4990000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23657000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-480571000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-337793000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-418706000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-701178000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-230000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1475000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4860000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-480341000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
us-gaap Profit Loss
ProfitLoss
-413846000 USD
us-gaap Profit Loss
ProfitLoss
-701257000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1116000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2320000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-480341000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-335202000 USD
us-gaap Net Income Loss
NetIncomeLoss
-413846000 USD
us-gaap Net Income Loss
NetIncomeLoss
-698937000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1194071476 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1194071476 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1010230470 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1010230470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1191521766 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1191521766 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1007967904 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1007967904 shares
CY2021Q2 bgne Earnings Per American Depository Share Per Share
EarningsPerAmericanDepositorySharePerShare
-5.23
CY2020Q2 bgne Earnings Per American Depository Share Per Share
EarningsPerAmericanDepositorySharePerShare
-4.31
bgne Earnings Per American Depository Share Per Share
EarningsPerAmericanDepositorySharePerShare
-4.52
bgne Earnings Per American Depository Share Per Share
EarningsPerAmericanDepositorySharePerShare
-9.01
CY2021Q2 bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
91851652 shares
CY2021Q2 bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
91851652 shares
CY2020Q2 bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
77710036 shares
CY2020Q2 bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
77710036 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
91655520 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
91655520 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
77535993 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
77535993 shares
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-480341000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
us-gaap Profit Loss
ProfitLoss
-413846000 USD
us-gaap Profit Loss
ProfitLoss
-701257000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9626000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1732000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5864000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2617000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
136000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-361000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-599000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4470000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1072000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1228000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-471450000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-339056000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
43000000 USD
bgne Amortization Of Research And Development Financing Liability
AmortizationOfResearchAndDevelopmentFinancingLiability
-53902000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-700235000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-408693000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-702646000 USD
us-gaap Profit Loss
ProfitLoss
-413846000 USD
bgne Amortization Of Research And Development Financing Liability
AmortizationOfResearchAndDevelopmentFinancingLiability
-55240000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1103000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2411000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-471450000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-337953000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-408693000 USD
us-gaap Profit Loss
ProfitLoss
-701257000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21159000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15617000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
110624000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
83723000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6033000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11264000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
53500000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-108000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-295171000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-12311000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1060000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
11212000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-7064000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13338000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9094000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28294000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4681000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
77204000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
51962000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-42558000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34851000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1688000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
41465000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
138877000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3189000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-604886000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80920000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54138000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1357051000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2442943000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1997515000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
997242000 USD
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
8500000 USD
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
43000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7500000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2025000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
543544000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1544864000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2162407000 USD
bgne Proceeds From Research And Development Financing Liability
ProceedsFromResearchAndDevelopmentFinancingLiability
0 USD
bgne Proceeds From Research And Development Financing Liability
ProceedsFromResearchAndDevelopmentFinancingLiability
616834000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
10819000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
49525000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
112589000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
26197000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
15959000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
35601000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
28198000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
143050000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2883161000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5257000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4287000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
396680000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
729124000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1390005000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
620775000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1786685000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1349899000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1776448000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1345014000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
310000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
283000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9927000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4602000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14527000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9250000 USD
us-gaap Interest Paid Net
InterestPaidNet
14267000 USD
us-gaap Interest Paid Net
InterestPaidNet
3354000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28885000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
28962000 USD
bgne Acquired In Process Research And Development But Not Yet Paid
AcquiredInProcessResearchAndDevelopmentButNotYetPaid
45000000 USD
bgne Acquired In Process Research And Development But Not Yet Paid
AcquiredInProcessResearchAndDevelopmentButNotYetPaid
0 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3869243000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
25754000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45833000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3738000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
66495000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4003587000 USD
CY2021Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9847000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
64791000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8891000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-480341000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3606775000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
978355000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
11629000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38255000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1349000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-364939000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2827056000 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
16569000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45468000 USD
CY2020Q2 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
3545000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2738000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2546492000 USD
CY2021Q2 bgne Number Of Molecules
NumberOfMolecules
10 molecule
CY2021Q2 bgne Number Of Persons
NumberOfPersons
1600 people
CY2021Q2 bgne Product Candidate
ProductCandidate
3 product
CY2021Q2 bgne Products In Commercial Or Clinical Development
ProductsInCommercialOrClinicalDevelopment
45 product
CY2021Q2 dei Entity Number Of Employees
EntityNumberOfEmployees
6400 employee
CY2021Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
18 country
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</span></div>
CY2021Q2 bgne Reimbursement Expense
ReimbursementExpense
8928000 USD
CY2020Q2 bgne Reimbursement Expense
ReimbursementExpense
0 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
9705000 USD
bgne Reimbursement Expense
ReimbursementExpense
15176000 USD
bgne Reimbursement Expense
ReimbursementExpense
0 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
10237000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
8055000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2605653000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
201000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2605452000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3267875000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
850000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3268725000 USD
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
18712000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
44856000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19330000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10806000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1378000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
61925000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
68585000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
117587000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
89293000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
413476000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
345261000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97173000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
73354000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
395167000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357686000 USD
CY2021Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
78864000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
85779000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
11223000 USD
us-gaap Depreciation
Depreciation
20667000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
7679000 USD
us-gaap Depreciation
Depreciation
15146000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15816000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3808000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12008000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8316000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3316000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5000000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
304000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
188000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
492000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
471000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
727000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1453000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1453000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1453000 USD
CY2021Q2 bgne Finite Lived Intangible Asset Expected Amortization After Year Three
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree
6922000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-230000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4860000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1475000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8306000 USD
CY2021Q2 bgne Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives
UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives
579000 USD
bgne Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives
UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives
1183000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
112000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-46000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
121000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
bgne Accounts Receivable Allowance For Credit Loss Exchange Rate Changes
AccountsReceivableAllowanceForCreditLossExchangeRateChanges
1000 USD
bgne Accounts Receivable Allowance For Credit Loss Exchange Rate Changes
AccountsReceivableAllowanceForCreditLossExchangeRateChanges
0 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
67000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
121000 USD
CY2021Q2 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
73563000 USD
CY2020Q4 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
71341000 USD
CY2021Q2 us-gaap Prepaid Taxes
PrepaidTaxes
26941000 USD
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
30392000 USD
CY2021Q2 bgne Payroll Tax Receivable Current
PayrollTaxReceivableCurrent
29141000 USD
CY2020Q4 bgne Payroll Tax Receivable Current
PayrollTaxReceivableCurrent
3580000 USD
CY2021Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3504000 USD
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4464000 USD
CY2021Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
6916000 USD
CY2020Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
6619000 USD
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
7113000 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1347000 USD
CY2021Q2 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
51408000 USD
CY2020Q4 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
25996000 USD
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5108000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4607000 USD
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
21761000 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
11666000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
225455000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160012000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
109000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
109000 USD
CY2021Q2 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
24244000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
14577000 USD
CY2020Q4 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
16984000 USD
CY2021Q2 bgne Prepaid Construction Cost
PrepaidConstructionCost
23096000 USD
CY2020Q4 bgne Prepaid Construction Cost
PrepaidConstructionCost
29778000 USD
CY2021Q2 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
23600000 USD
CY2020Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
10913000 USD
CY2021Q2 bgne Rental Deposits And Other
RentalDepositsAndOther
7244000 USD
CY2020Q4 bgne Rental Deposits And Other
RentalDepositsAndOther
5962000 USD
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
53951000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
49344000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
132244000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
113090000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
81795000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
106765000 USD
CY2021Q2 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
169826000 USD
CY2020Q4 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
143302000 USD
CY2021Q2 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
73073000 USD
CY2020Q4 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
66131000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
36074000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
14373000 USD
CY2021Q2 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
25572000 USD
CY2020Q4 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
11874000 USD
CY2021Q2 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
12516000 USD
CY2020Q4 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
3699000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
398856000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
346144000 USD
CY2021Q2 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
47403000 USD
CY2020Q4 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
49139000 USD
CY2021Q2 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
7752000 USD
CY2020Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
8113000 USD
CY2021Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
176000 USD
CY2020Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
177000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55331000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
57429000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
434802000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2807349000 CNY
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
335015000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2185928000 CNY
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
194856000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1258111000 CNY
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
183637000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1198206000 CNY
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
7627000 USD
CY2021Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
147000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
251000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1888000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
3607000 USD
CY2020Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
57000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
124000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-480341000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
us-gaap Profit Loss
ProfitLoss
-413846000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1194071476 shares
us-gaap Profit Loss
ProfitLoss
-701257000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1116000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2320000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-480341000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-335202000 USD
us-gaap Net Income Loss
NetIncomeLoss
-413846000 USD
us-gaap Net Income Loss
NetIncomeLoss
-698937000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1194071476 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1010230470 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1010230470 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1191521766 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1191521766 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1007967904 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1007967904 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
64791000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45468000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
110624000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
83723000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
5215000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
62000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5153000 USD
CY2021Q2 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2021Q2 bgne Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital
RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital
0.50
CY2021Q2 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
220147000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
149992000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65635000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
755864000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117694000 USD
CY2021Q2 dei Entity Number Of Employees
EntityNumberOfEmployees
6400 employee
CY2021Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
18 country
CY2021Q2 bgne Number Of Molecules
NumberOfMolecules
10 molecule
CY2021Q2 bgne Number Of Persons
NumberOfPersons
1600 people
CY2021Q2 bgne Product Candidate
ProductCandidate
3 product
CY2021Q2 bgne Products In Commercial Or Clinical Development
ProductsInCommercialOrClinicalDevelopment
45 product

Files In Submission

Name View Source Status
0001651308-21-000172-index-headers.html Edgar Link pending
0001651308-21-000172-index.html Edgar Link pending
0001651308-21-000172.txt Edgar Link pending
0001651308-21-000172-xbrl.zip Edgar Link pending
bgne-20210630.htm Edgar Link pending
bgne-20210630.xsd Edgar Link pending
bgne-20210630_cal.xml Edgar Link unprocessable
bgne-20210630_def.xml Edgar Link unprocessable
bgne-20210630_htm.xml Edgar Link completed
bgne-20210630_lab.xml Edgar Link unprocessable
bgne-20210630_pre.xml Edgar Link unprocessable
bgnelogo.jpg Edgar Link pending
exhibit101-rsuawardagreeme.htm Edgar Link pending
exhibit10101-employmentcon.htm Edgar Link pending
exhibit10102-renewedemploy.htm Edgar Link pending
exhibit1011-consultingagre.htm Edgar Link pending
exhibit102-rsuawardagreeme.htm Edgar Link pending
exhibit103-rsuawardagreeme.htm Edgar Link pending
exhibit104-nqstockoptionag.htm Edgar Link pending
exhibit105-nqstockoptionag.htm Edgar Link pending
exhibit106-nqstockoptionag.htm Edgar Link pending
exhibit107-3rdarespp.htm Edgar Link pending
exhibit109-offerletterjuli.htm Edgar Link pending
exhibit311-2021q2.htm Edgar Link pending
exhibit312-2021q2.htm Edgar Link pending
exhibit321-2021q2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending